ACE inhibitors and COVID-19: We don't know yet.

Khashkhusha, Taqua R; Chan, Jeffrey Shi Kai; Harky, Amer

Khashkhusha, Taqua R; Chan, Jeffrey Shi Kai; Harky, Amer.

Khashkhusha TR; School of Medicine, University of Liverpool, Liverpool, United Kingdom.
Chan JSK; Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Harky A; Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

J Card Surg ; 35(6): 1172-1173, 2020 Jun.

Article in English | MEDLINE | ID: covidwho-611541

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/adverse effects; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Betacoronavirus; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Receptor, Angiotensin, Type 2/metabolism; COVID-19; Coronary Disease/complications; Coronavirus Infections/etiology; Humans; Hypertension/complications; Hypertension/drug therapy; Pandemics; Pneumonia, Viral/etiology; SARS-CoV-2; COVID-19 Drug Treatment

Keywords

ACEI; COVID-19; coronavirus

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Receptor, Angiotensin, Type 2 / Betacoronavirus Topics: Long Covid Limits: Humans Language: English Journal: J Card Surg Journal subject: Cardiology Year: 2020 Document Type: Article Affiliation country: Jocs.14582

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google